Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Thirteen Companies Boosting Distributions For Long-Term Shareholders
Article By:
Dividend Growth Investor
Monday, December 17, 2018 1:16 PM EST
An increase that is well below the rate of dividend growth indicates caution, while an increase that is close to or higher than the average indicates optimism.
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By:
Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By:
Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EST
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
July 2017 Stock Considerations
I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.